BioCentury
ARTICLE | Company News

BTG, Eckert & Ziegler deal

September 23, 2013 7:00 AM UTC

Eckert & Ziegler acquired all of BTG's brachytherapy assets, including products which are used to treat early stage prostate cancer, associated IP and a facility in Oxford, Conn. BTG will receive $5 m...